{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:06:07Z","timestamp":1793120767323,"version":"4.5.0"},"reference-count":51,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Clostridioides difficile infection (CDI) is a leading healthcare-associated infection worldwide, causing significant morbidity, mortality, healthcare burden, and costs. Clinical manifestations range from mild, self-limiting diarrhea to severe, life-threatening complications such as toxic megacolon and septic shock. Early identification of patients at high risk of severe disease is essential to guide clinical decision-making and optimize therapy. This narrative review summarizes recent epidemiological data, current trends, and known risk factors as clinical context for severity prediction and then examines the utility and limitations of biomarkers that may predict CDI severity, including inflammatory, hematological, fecal, renal, and immune-response biomarkers. While some markers are already used in guideline-based assessment or routine clinical practice (e.g., C-reactive protein, white blood cell count, serum creatinine), they have limited specificity. Other markers emerging from CDI research, including procalcitonin, interleukins, and presepsin, may provide complementary prognostic information. The key challenge is not simply to identify additional biomarkers but to determine which biomarkers are clinically useful, at which stage of CDI progression, and in which patients they add value beyond conventional severity criteria. Validated predictive models integrating combinations of these biomarkers with clinical and microbiological data are needed to support early risk stratification and therapeutic decision-making at the time of diagnosis.<\/jats:p>","DOI":"10.3390\/medicina62071311","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:53:46Z","timestamp":1783418026000},"page":"1311","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Biomarkers for Early Severity Prediction in Clostridioides difficile Infection: Current Evidence, Clinical Utility, and Future Directions"],"prefix":"10.3390","volume":"62","author":[{"given":"Bianca","family":"Balas-Maftei","sequence":"first","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen-Elena","family":"Florea","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Abudanii","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, \u201cSf\u00e2nta Parascheva\u201d Clinical Hospital for Infectious Diseases, 700116 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana Adelina","family":"Stoian","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4356-4957","authenticated-orcid":false,"given":"Constantin Aleodor","family":"Costin","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Grigoriu","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Department of Infectious Diseases, \u201cSf\u00e2nta Parascheva\u201d Clinical Hospital for Infectious Diseases, 700116 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Irimie-Baluta","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana-Manuela","family":"Sandu","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Department of Infectious Diseases, \u201cSf\u00e2nta Parascheva\u201d Clinical Hospital for Infectious Diseases, 700116 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Rotaru","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9447-0182","authenticated-orcid":false,"given":"Carmen","family":"Manciuc","sequence":"additional","affiliation":[{"name":"Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania"},{"name":"Department of Infectious Diseases, \u201cSf\u00e2nta Parascheva\u201d Clinical Hospital for Infectious Diseases, 700116 Ia\u0219i, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Akorful, R.A.A., Odoom, A., Awere-Duodu, A., and Donkor, E.S. (2025). The Global Burden of Clostridioides difficile Infections, 2016\u20132024: A Systematic Review and Meta-Analysis. Infect. Dis. Rep., 17.","DOI":"10.3390\/idr17020031"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/1469-0691.12769","article-title":"Humoral Immune Response as Predictor of Recurrence in Clostridium difficile Infection","volume":"20","author":"Bauer","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_3","first-page":"280","article-title":"Clostridioides difficile Infection: An Update","volume":"32","author":"Salvati","year":"2024","journal-title":"Infez. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e0013523","DOI":"10.1128\/cmr.00135-23","article-title":"Clostridioides difficile Infection: History, Epidemiology, Risk Factors, Prevention, Clinical Manifestations, Treatment, and Future Options","volume":"37","author":"Sanson","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection","volume":"20","author":"Debast","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3201\/eid1503.080312","article-title":"Clinical Risk Factors for Severe Clostridium difficile-Associated Disease","volume":"15","author":"Henrich","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ajic.2016.04.231","article-title":"Predictors of Clostridium difficile Infection-Related Mortality among Older Adults","volume":"44","author":"Chopra","year":"2016","journal-title":"Am. J. Infect. Control"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes","volume":"382","author":"Guh","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile Infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/QCO.0b013e32834748e5","article-title":"Epidemiology and Control of Clostridium difficile Infections in Healthcare Settings: An Update","volume":"24","author":"Barbut","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/cid\/ciy845","article-title":"Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention","volume":"68","author":"Revolinski","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1172\/JCI72336","article-title":"Clostridium difficile and the Microbiota","volume":"124","author":"Seekatz","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-micro-091014-104115","article-title":"Interactions Between the Gastrointestinal Microbiome and Clostridium difficile","volume":"69","author":"Theriot","year":"2015","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"16020","DOI":"10.1038\/nrdp.2016.20","article-title":"Clostridium difficile Infection","volume":"2","author":"Smits","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Czepiel, J., Krutova, M., Mizrahi, A., Khanafer, N., Enoch, D.A., Patyi, M., Deptu\u0142a, A., Agodi, A., Nuvials, X., and Pituch, H. (2021). Mortality Following Clostridioides difficile Infection in Europe: A Retrospective Multicenter Case-Control Study. Antibiotics, 10.","DOI":"10.3390\/antibiotics10030299"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.cmi.2016.03.010","article-title":"European Society of Clinical Microbiology and Infectious Diseases: Update of the Diagnostic Guidance Document for Clostridium difficile Infection","volume":"22","author":"Crobach","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8034","DOI":"10.3748\/wjg.v19.i44.8034","article-title":"Predictors of Clostridium difficile Infection Severity in Patients Hospitalised in Medical Intensive Care","volume":"19","author":"Khanafer","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Miller, M.A., Louie, T., Mullane, K., Weiss, K., Lentnek, A., Golan, Y., Kean, Y., and Sears, P. (2013). Derivation and Validation of a Simple Clinical Bedside Score (ATLAS) for Clostridium difficile Infection Which Predicts Response to Therapy. BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-148"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/cid\/ciab737","article-title":"External Validation and Comparison of Clostridioides difficile Severity Scoring Systems","volume":"74","author":"Perry","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e0067622","DOI":"10.1128\/aac.00676-22","article-title":"Validation of Clinical Risk Models for Clostridioides difficile-Attributable Outcomes","volume":"66","author":"Madden","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","article-title":"Host and Pathogen Factors for Clostridium difficile Infection and Colonization","volume":"365","author":"Loo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"16108","DOI":"10.1038\/nmicrobiol.2016.108","article-title":"The Binary Toxin CDT Enhances Clostridium difficile Virulence by Suppressing Protective Colonic Eosinophilia","volume":"1","author":"Cowardin","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1884516","DOI":"10.1080\/19490976.2021.1884516","article-title":"The Prognostic Value of Toxin B and Binary Toxin in Clostridioides difficile Infection","volume":"13","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3201\/eid\/1706.101483","article-title":"Binary Toxin and Death after Clostridium difficile Infection","volume":"17","author":"Bacci","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nature09397","article-title":"The Role of Toxin A and Toxin B in Clostridium difficile Infection","volume":"467","author":"Kuehne","year":"2010","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-8981(02)00101-8","article-title":"Pathobiochemistry and Clinical Use of Procalcitonin","volume":"323","author":"Meisner","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/gut.38.3.337","article-title":"Effect of Clostridium difficile Toxin A on Human Intestinal Epithelial Cells: Induction of Interleukin 8 Production and Apoptosis after Cell Detachment","volume":"38","author":"Mahida","year":"1996","journal-title":"Gut"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rao, K., Erb-Downward, J.R., Walk, S.T., Micic, D., Falkowski, N., Santhosh, K., Mogle, J.A., Ring, C., Young, V.B., and Huffnagle, G.B. (2014). The Systemic Inflammatory Response to Clostridium difficile Infection. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092578"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archsurg.2009.51","article-title":"Fulminant Clostridium difficile Colitis: Patterns of Care and Predictors of Mortality","volume":"144","author":"Sailhamer","year":"2009","journal-title":"Arch. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e142976","DOI":"10.1172\/jci.insight.142976","article-title":"Fecal Host Biomarkers Predicting Severity of Clostridioides difficile Infection","volume":"6","author":"Golizeh","year":"2021","journal-title":"JCI Insight"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-Reactive Protein: A Critical Update","volume":"111","author":"Pepys","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/0974-777X.162229","article-title":"The Role of Procalcitonin Levels in Assessing the Severity of Clostridium difficile Infection","volume":"7","author":"Dazley","year":"2015","journal-title":"J. Glob. Infect. Dis."},{"key":"ref_35","first-page":"313","article-title":"Can Procalcitonin Contribute to the Diagnosis of Clostridium difficile Colitis?","volume":"19","author":"Shapiro","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Hamo, Z., Azrad, M., Nitzan, O., Sagie, A., Tkhawkho, L., Binyamin, D., and Peretz, A. (2017). Role of Single Procalcitonin Test on Admission as a Biomarker for Predicting the Severity of Clostridium difficile Infection. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.02532"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhin.2011.04.017","article-title":"CSI: A Severity Index for Clostridium difficile Infection at the Time of Admission","volume":"79","author":"Lungulescu","year":"2011","journal-title":"J. Hosp. Infect."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Wen, B.-J., Te, L.-G., Liu, X.-X., and Zhao, J.-H. (2022). The Value of Fecal Calprotectin in Clostridioides difficile Infection: A Systematic Review. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.881816"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MPG.0b013e318262a718","article-title":"Fecal Calprotectin as a Correlative Marker in Clinical Severity of Infectious Diarrhea and Usefulness in Evaluating Bacterial or Viral Pathogens in Children","volume":"55","author":"Chen","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/IPC.0000000000000312","article-title":"Fecal Calprotectin in the Diagnosis of Clostridium difficile Infection","volume":"24","author":"Hanania","year":"2015","journal-title":"Infect. Dis. Clin. Pract."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Swale, A., Miyajima, F., Roberts, P., Hall, A., Little, M., Beadsworth, M.B.J., Beeching, N.J., Kolamunnage-Dona, R., Parry, C.M., and Pirmohamed, M. (2014). Calprotectin and Lactoferrin Faecal Levels in Patients with Clostridium difficile Infection (CDI): A Prospective Cohort Study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106118"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1128\/JCM.02735-12","article-title":"Quantitative Fecal Lactoferrin in Toxin-Positive and Toxin-Negative Clostridium difficile Specimens","volume":"51","author":"LaSala","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s10096-013-1905-x","article-title":"Elevated Lactoferrin Is Associated with Moderate to Severe Clostridium difficile Disease, Stool Toxin, and 027 Infection","volume":"32","author":"Boone","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s10156-011-0254-x","article-title":"Usefulness of Presepsin (sCD14-ST) Measurements as a Marker for the Diagnosis and Severity of Sepsis That Satisfied Diagnostic Criteria of Systemic Inflammatory Response Syndrome","volume":"17","author":"Shozushima","year":"2011","journal-title":"J. Infect. Chemother. Off. J. Jpn. Soc. Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cca.2018.09.013","article-title":"Comparison of Accuracy of Presepsin and Procalcitonin Concentrations in Diagnosing Sepsis in Patients with and without Acute Kidney Injury","volume":"490","author":"Nakamura","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e030421","DOI":"10.1136\/bmjopen-2019-030421","article-title":"Diagnostic Accuracy of Presepsin in Predicting Bacteraemia in Elderly Patients Admitted to the Emergency Department: Prospective Study in Japan","volume":"9","author":"Imai","year":"2019","journal-title":"BMJ Open"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1099\/jmm.0.000278","article-title":"Diagnostic Accuracy of Presepsin (sCD14-ST) and Procalcitonin for Prediction of Bacteraemia and Bacterial DNAaemia in Patients with Suspected Sepsis","volume":"65","author":"Leli","year":"2016","journal-title":"J. Med. Microbiol."},{"key":"ref_48","first-page":"1395","article-title":"Role of Presepsin for the Evaluation of Sepsis in the Emergency Department","volume":"52","author":"Pizzolato","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/bjs.8868","article-title":"Systematic Review and Meta-Analysis of Outcomes Following Emergency Surgery for Clostridium difficile Colitis","volume":"99","author":"Bhangu","year":"2012","journal-title":"Br. J. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Yu, S., Ge, X., Xu, H., Tan, B., Tian, B., Shi, Y., Dai, Y., Li, Y., Hu, S., and Qian, J. (2023). Gut Microbiome and Mycobiome in Inflammatory Bowel Disease Patients with Clostridioides difficile Infection. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1129043"},{"key":"ref_51","first-page":"2423","article-title":"Faecal Lactoferrin and Calprotectin in Patients with Clostridium difficile Infection: A Case-Control Study","volume":"36","author":"Barbut","year":"2017","journal-title":"Eur. J. Clin."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1311\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:37:24Z","timestamp":1783427844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071311"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071311","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}